Literature DB >> 9492104

Effect of low-dose methylprednisolone on calcium balance and bone composition in rats.

A Voulgaris1, C Liapi, J Papadopoulos.   

Abstract

Glucocorticoid induced osteoporosis has been associated with high doses and it has been partially attributed to decreased absorption and to increased calcium excretion. The present study examined the effect of low but effective doses of methylprednisolone (MP) on calcium balance and on skeleton in rats. Total duration of the experiment 29 days. Thirty-one male Wistar rats (MP group) were injected with 4mg/kg body weight MP s.c. at the 1st, 11th and 20th day of the experiment and 28 rats (C group) were used as matched controls. The 1st, 11th and 20th day of the experiment rats were placed in individual metabolic cages for three days. Food and water consumption were measured at the 2nd and 3rd days after each injection; urine and faeces were collected at the same days for calcium estimation. Calcium intake and excretion after each injection was significantly lower in the MP group as compared to controls. A statistically significant positive correlation between calcium consumption and calcium excretion was found in both groups resulting in a negative final balance. Rats were killed the 29th day. Adrenal weight was statistically significant lower in MP group (p<0.001). Morphometric properties were evaluated for the right femur. No significant difference was found between the two groups. Mineral and calcium content was slightly increased in the MP group. According to these results, it seems that methylprednisolone while effective on HPA axis did not have any effect on calcium absorption and on bone calcium deposition in rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9492104     DOI: 10.1007/BF03348027

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  THE EFFECT OF OESTROGENS, ANDROGENS AND CORTICOIDS ON SKELETAL KINETICS IN MAN.

Authors:  G S GORDAN; E EISENBERG
Journal:  Proc R Soc Med       Date:  1963-11

2.  The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932.

Authors:  H Cushing
Journal:  Obes Res       Date:  1994-09

Review 3.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

4.  Cortisol decreases bone formation by inhibiting periosteal cell proliferation.

Authors:  Y S Chyun; B E Kream; L G Raisz
Journal:  Endocrinology       Date:  1984-02       Impact factor: 4.736

5.  Glucocorticoid receptor in clonal osteosarcoma cell lines: a novel system for investigating bone active hormones.

Authors:  M R Haussler; S C Manolagas; L J Deftos
Journal:  Biochem Biophys Res Commun       Date:  1980-05-14       Impact factor: 3.575

6.  Prednisone-induced osteopenia in beagles: variable effects mediated by differential suppression of bone formation.

Authors:  L D Quarles
Journal:  Am J Physiol       Date:  1992-07

7.  Bone studies in patients on prolonged systemic corticosteroid therapy for asthma.

Authors:  P A Greenberger; R W Hendrix; R Patterson; J S Chmiel
Journal:  Clin Allergy       Date:  1982-07

8.  Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy.

Authors:  O S Gluck; W A Murphy; T J Hahn; B Hahn
Journal:  Arthritis Rheum       Date:  1981-07

9.  The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross-sectional and a longitudinal study using single photon absorptiometry.

Authors:  C N de Deuxchaisnes; J P Devogelaer; W Esselinckx; B Bouchez; G Depresseux; C Rombouts-Lindemans; J P Huaux
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

10.  Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women.

Authors:  A G Need; J C Philcox; T F Hartley; B E Nordin
Journal:  Aust N Z J Med       Date:  1986-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.